Biomarker identification important for future of chronic inflammatory bowel disease treatment: GlobalData
Increased demand for preventative healthcare has led to exponential boom in nutraceutical business: Dr. Vivek Srivastav, Senior VP, Zeon Lifesciences
India is on cusp of massive leap towards being global biopharma leader: Gaurav Kaushik, Meteoric Biopharmaceuticals
Affordability and accessibility of genetic tests still a challenge in India: Dr. Ramprasad, CEO, MedGenome Labs
We have significant plans to introduce our global drugs and therapy pipeline in India: Gagandeep Singh, MD, AstraZeneca Pharma India
FE Exclusive | Therapies like once-a-week insulin, obesity-specific treatments to be launched in India soon: Vikrant Shrotriya, MD, Novo Nordisk India
